Both Wegovy and Mounjaro, target adults with obesity or type 2 diabetes, but Mounjaro is also approved for weight management in the UK. Wegovy uses semaglutide to mimic GLP-1, a gut hormone that curbs appetite. Mounjaro uses tirzepatide to mimic both GLP-1 and GIP, another gut hormone that helps regulate blood sugar.
While both medications have side effects like nausea and require a high BMI for prescription, Mounjaro seems more effective for weight loss at higher doses. However, Mounjaro might be pricier and harder to find, especially in higher doses. Ultimately, consulting a doctor helps determine the best medication for your individual needs.
Original article posted here: https://www.thelondonobesityclinic.com/wegovy-semaglutide-vs-mounjaro-tirzepatide/
